This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2003 Nov 5;290(17):2322-4.

doi: 10.1001/jama.290.17.2322.

High-density lipoproteins as an emerging therapeutic target for atherosclerosis

PMID: 14600193
DOI: 10.1001/jama.290.17.2322

Editorial

High-density lipoproteins as an emerging therapeutic target for atherosclerosis

Daniel J Rader. JAMA. 2003.

. 2003 Nov 5;290(17):2322-4.

doi: 10.1001/jama.290.17.2322.

Author

PMID: 14600193
DOI: 10.1001/jama.290.17.2322

No abstract available

PubMed Disclaimer

Comment on

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.
Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, Yasin M, Eaton GM, Lauer MA, Sheldon WS, Grines CL, Halpern S, Crowe T, Blankenship JC, Kerensky R. Nissen SE, et al. JAMA. 2003 Nov 5;290(17):2292-300. doi: 10.1001/jama.290.17.2292. JAMA. 2003. PMID: 14600188 Clinical Trial.

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information